Peter Thompson MD Overview
- Company
- Edgewise Therape...
- Primary Position
-
Co-Founder & Cha...
- Primary Industry
-
Healthcare
- Active Board Seats
-
11
- Med. Deal Size
-
- Med. Valuation
-
Peter Thompson MD General Information
Biography
Dr. Peter Thompson serves as a General Partner at OrbiMed. He serves as Board Member at Ottimo Pharma. Dr. Thompson is a Co-Founder & serves as Co-Chief Executive Officer & Board Chairman at Terremoto Biosciences. He also served as a Board Member at Janux Therapeutics. He is a Co-Founder and serves as Chairman at Edgewise Therapeutics. He is a Co-Founder and serves as a Board Member at Cleave Therapeutics. He serves as a Board Member at Sparrow Pharmaceuticals. He serves as a Board Member at Sionna. He co-founded and served as Chairman at Silverback Therapeutics. He serves as a Board Member at Decibel Therapeutics. He is a Co-Founder and serves as Chairman at Edgewise Therapeutics. He served as a Board Member at Prevail Therapeutics, Aspen Neuroscience, and Principia Biopharma. He served as a Board Member at Alpine Immune Sciences.
Contact Information
Address
- 1715 38th Street
- Boulder, CO 80301
- United States
Peter Thompson MD Positions (4)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Cleave Therapeutics | Company | Co-Founder and Board Member | San Francisco, CA | Drug Discovery | |
| Corvus Pharmaceuticals | Company | Co-Founder & Board Member | Burlingame, CA | Drug Discovery | |
| OrbiMed | Service Provider | General Partner | New York, NY | Lender | |
| Terremoto Biosciences | Company | Co-Founder, Co-Chief Executive Officer & Chairman | San Francisco, CA | Drug Delivery |
Peter Thompson MD Board Seats (11)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Alpheus Medical | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Chanhassen, MN | |
| Aspen Neuroscience | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | San Diego, CA | |
| Cleave Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | San Francisco, CA | |
| Corvus Pharmaceuticals | Drug Discovery | Publicly Held | Formerly VC-backed | Burlingame, CA | |
| Decibel Therapeutics | Drug Discovery | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | Boston, MA |
Peter Thompson MD Lead Partner on Deals (44)
Peter Thompson MD has been the lead partner on 44 deals. Their latest deal was with Ottimo Pharma, a drug discovery company. The deal was made for on 12-Dec-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Ottimo Pharma | 12-Dec-2024 | Later Stage VC (Series A) | Completed | Drug Discovery | Sandwich, United Kingdom | |
| Sionna | 05-Mar-2024 | Completed | Drug Discovery | Waltham, MA | ||
| Terremoto Biosciences | 02-Nov-2023 | Completed | Drug Delivery | San Francisco, CA | ||
| Terremoto Biosciences | 25-May-2022 | Completed | Drug Delivery | San Francisco, CA | ||
| Sionna | 02-Feb-2022 | Completed | Drug Discovery | Waltham, MA | ||
| Sparrow Pharmaceuticals | 01-Jan-2022 | Completed | Drug Discovery | Portland, OR | ||
| Alpheus Medical | 17-Nov-2021 | Completed | Surgical Devices | Chanhassen, MN | ||
| Alpine Immune Sciences | 14-Sep-2021 | Completed | Pharmaceuticals | Seattle, WA | ||
| Janux Therapeutics | 20-Apr-2021 | Early Stage VC (Series B) | Completed | Drug Discovery | San Diego, CA | |
| Janux Therapeutics | 02-Mar-2021 | Early Stage VC (Series A) | Completed | Drug Discovery | San Diego, CA |
Peter Thompson MD Network (523)
Board Members (231)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Brian Levy | InflammX | InflammX | Tampa, FL | |
| Alana McNulty | Janux Therapeutics | Self | San Diego, CA | |
| Decibel Therapeutics | Self | Boston, MA | ||
| Synthorx | Avalon Ventures | La Jolla, CA | ||
| Principia Biopharma | Self | San Francisco, CA |
Portfolio Executives (263)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Fredric Anderson | Ottimo Pharma | Senior Vice President of Finance | 12-Dec-2024 | Sandwich, United Kingdom |
| Mehdi Shahidi | Ottimo Pharma | Chief Medical Officer and Head of Development | 12-Dec-2024 | Sandwich, United Kingdom |
| Ottimo Pharma | Vice Chairman | 12-Dec-2024 | Sandwich, United Kingdom | |
| Ottimo Pharma | Co-Founder, Chief Scientific Advisor and Board Member | 12-Dec-2024 | Sandwich, United Kingdom | |
| Ottimo Pharma | Chief Technical and Quality Officer | 12-Dec-2024 | Sandwich, United Kingdom |
Fund Team Members (29)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Ronny Ginor MD | OrbiMed | OrbiMed Israel Partners II | New York, NY |
| Vivek Sivathanu Ph.D | OrbiMed | OrbiMed Israel Partners II | New York, NY |
| OrbiMed | New York, NY | ||
| OrbiMed | New York, NY | ||
| OrbiMed | New York, NY |
Peter Thompson MD Affiliated Funds (15)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| OrbiMed Private Investments VIII | OrbiMed | Venture - General | Closed | 2021 | ||||
| OrbiMed Private Investments VI | OrbiMed | Venture - General | Fully Invested | 2015 | ||||
| OrbiMed Asia Partners II | OrbiMed | Growth/Expansion | Closed | 2014 | ||||
| OrbiMed Private Investments V | OrbiMed | Venture - General | Fully Invested | 2013 | ||||
| OrbiMed Israel Partners | OrbiMed | Venture - General | Closed | 2012 |
Peter Thompson MD FAQs
-
Who is Peter Thompson MD?
Dr. Peter Thompson serves as a General Partner at OrbiMed.
-
How much does Peter Thompson MD typically invest?
Peter Thompson MD's median deal size is .
-
What is Peter Thompson MD’s main position?
Peter Thompson MD’s primary position is Co-Founder & Chairman.
-
What are the contact details for Peter Thompson MD?
Peter Thompson MD’s email address is pe and his phone number is +1 (206) .
-
How many active board seats does Peter Thompson MD hold?
Peter Thompson MD holds 11 board seats including Alpheus Medical, Aspen Neuroscience, Cleave Therapeutics, Corvus Pharmaceuticals, and Decibel Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
